Advocacy intelligence hub — real-time data for patient organizations
Meyer Children's Hospital IRCCS
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Fasenra
AstraZeneca Pharmaceuticals LP
Fasenra
(benralizumab)Orphan drugstandardAstraZeneca Pharmaceuticals LP
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
12.1 Mechanism of Action Benralizumab is a humanized afucosylated, monoclonal antibody (IgG1, kappa) that directly binds to the alpha subunit of the h...
Jason C Sluzevich, M.D., MD
Mayo Clinic
📍 JACKSONVILLE, FL
Filip De Keyser, MD, PhD
University Hospital, Ghent
Amal Fawzy, Ph.d
Faculty of Physical Therapy, Ahram Canadian University
H. Knaapen, MD
Radboud University Medical Center
Ulrike Blume-Peytavi, Prof. MD
ulrike.blume-peytavi@charite.de
Karen Delavigne
The Cancer University of Toulouse Oncopole